Brief: Microbot Medical Submits An IDE Application To Gain FDA Approval
05/02/2024 12:45
Feb 5 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL SUBMITS AN IDE APPLICATION TO GAIN FDA
APPROVAL
TO COMMENCE ITS PIVOTAL CLINICAL TRIAL IN THE US
Source text for Eikon: ID:nGNXbWyZWX
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones